• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Live UK pricing:

Futura Medical PLC (FUM)

ORD 0.2P
Sell: 0.18p|Buy: 0.184p|Change: 0.03 (-12.38%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment

This investment is listed on the Alternative Investment Market (AIM). Investments on this market can be higher risk and have lower liquidity, meaning they can be harder to buy or sell, and their prices may be more volatile. Before investing, make sure you understand the risks of investing.

Company profile

Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction (commercially available in multiple markets), Eroxon Intense (a new line extensionin development) and WSD4000 which is in-development female sexual health portfolio. Geographically, the company derives the majority of its revenue from the United Kingdom and the European Union followed by USA and rest of the world.

Address

40 Occam Road
Surrey Technology Centre
Guildford
Surrey
GBR
GU2 7YG

Telephone

+44 1483685670

Website

https://www.futuramedical.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Futura Medical PLC Second Quarter Earnings Results for 20272027-09-01T00:00:00
Futura Medical PLC Annual General Meeting for 20262027-06-29T09:00:00
Futura Medical PLC Annual Report for 20262027-06-04T00:00:00
Futura Medical PLC Fourth Quarter Earnings Conference Call for 20262027-04-29T09:00:00
Futura Medical PLC Fourth Quarter Earnings Results for 20262027-04-29T00:00:00

Previous key dates

NameKey Date
Futura Medical PLC Second Quarter Earnings Results for 20262026-09-01T00:00:00
Futura Medical PLC Annual General Meeting for 20252026-06-29T09:00:00
Futura Medical PLC Annual Report for 20252026-06-04T00:00:00
Futura Medical PLC Fourth Quarter Earnings Conference Call for 20252026-04-29T09:00:00
Futura Medical PLC Fourth Quarter Earnings Result for 20252026-04-29T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.